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Background: We aimed to evaluate the association between obstructive sleep apnea (OSA) and the
incidence of a series cardiovascular events in the elderly.
Methods: We systematically searched PubMed, Embase, Springer link, the Cochrane library, and two
Chinese databases (Wanfang data and CNKI database) for relevant studies which were published before
October 10, 2014 and recruited participants with a mean age of > 60 years. Risk ratios (RR) and 95%
conﬁdence intervals (CI) were used to evaluate the association between OSA and cardiovascular events or
mortality risk. Sensitivity analysis was performed by omitting each study according to different criteria.
In addition, Egger's test was used to assess the publication bias.
Results: A total of 11 studies with 22,046 participants were included in this meta-analysis. Our results
showed that OSA could signiﬁcantly increase the risk of cardiovascular disease [(CVD) RR ¼ 2.04, 95%
CI ¼ 1.28e3.23], stroke (RR ¼ 2.29, 95% CI ¼ 1.49e3.51) and all-cause mortality (RR ¼ 1.48, 95% CI ¼ 1.13
e1.94) for the elderly. However, no signiﬁcant association was found between OSA and coronary heart
disease [(CHD) RR ¼ 1.43, 95% CI ¼ 0.96e2.23]. Sensitivity analysis showed that the results were rela-
tively stable. In addition, no publication bias was observed.
Conclusion: OSA can signiﬁcantly increase the risk of CVD, stroke and all-cause mortality for the elderly.
However, no signiﬁcant association was observed between OSA and CHD.
Copyright © 2016, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
Obstructive sleep apnea (OSA) is characterized by reduced
airﬂow (hypopnea) or even a cessation in airﬂow (apnea) for at
least 10 seconds1. The incidence of OSA is reported to increase with
age. A general population-based study showed that up to 24% men
and 16%women suffered fromOSA in the elders aged 60e70 years2.
A study in community-dwelling elderly individuals demonstrates
that OSA occurs in more than one-third (38%) of people aged from
65 years to 82 years, and most patients with OSA showed left
ventricular ejection fraction < 50%3.re that they have no conﬂicts
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es/by-nc-nd/4.0/).Multiple studies have tried to identify whether OSA is associated
with a series of cardiovascular events, such as cardiovascular dis-
ease (CVD)4e6, coronary heart disease (CHD)7, and stroke8e10.
However, the association has not yet been identiﬁed convincingly
due to the variable methodologies and results across studies.
Although several systematical reviews and meta-analysis have
been published11e14, the elderly or Chinese population have not
been considered.
In this study, we aimed to explore the association between OSA
and the risk of some cardiovascular events (CVD, CHD, and stroke)
and all-cause mortality in the elderly by performing a meta-
analysis.2. Materials and Methods
2.1. Search strategy
We searched PubMed, Embase, Springer link, the Cochrane li-
brary, and two Chinese databases (Wanfang data and CNKIicine. Published by Elsevier Taiwan LLC. This is an open access article under the CC
Figure 1. The ﬂow diagram for study selection.
Meta-Analysis of OSA and Cardiovascular 165database) for relevant studies published before October 10, 2014.
There were no restrictions on study language. The search terms
were “sleep disordered breathing” or “obstructive sleep apnea” or
“sleep apnea” and “cardiovascular disease” or “coronary heart
disease” or “coronary artery disease” or “myocardial infarction” or
“stroke” and “prospective study” or “cohort study” or “longitudinal
study” or “follow-up study”. In addition, we manually searched the
printed papers and reference lists of relevant reviews and retrieved
articles to identify more relevant studies.
2.2. Literature screening and disease deﬁnition
The studies were included if they met the following criteria: (1)
prospective design; (2) investigated the associations between OSA
and cardiovascular events (CHD, CVD or stroke) or mortality risk;
(3) included patients with an average age of 60 years or older; and
(4) provided the risk ratios (RRs) and their 95% conﬁdence intervals
(95% CIs) or available data to calculate these estimates. Reviews,
letters, and reports were excluded.
CHDwas deﬁned as the presence of one ormore of the following
conditions: typical angina, prolonged chest pain, a history of cor-
onary artery angioplasty or bypass graft surgery, and/or a previous
admission to hospital for CHD15. CVD was deﬁned as self-reported
history of angina, myocardial infarction, congestive heart failure
valve disease, pacemaker, stroke and/or transient ischemic attack;
surgery history of atrial ﬁbrillation, coronary angioplasty, bypass
surgery, other heart surgery; and/or use of drugs such as nitrates,
digitalis, or class 1A antiarrhythmics16. Stroke was deﬁned as any
self-reported new temporary or permanent neurologic deﬁcit,
prolonged reversible ischemic neurologic deﬁcit or transient
ischemic attack; and/or conﬁrmed by computed tomography or
magnetic resonance imaging17.
2.3. Data extraction and quality assessment
Two investigators independently screened the studies according
to the inclusion and exclusion criteria, and extracted the following
data based on a standard form: name of the ﬁrst author, publication
year, study area, age of the participants, gender, diagnostic criteria
of OSA, sample size, duration of follow-up, outcomes, and adjusted
factors. After ﬁnishing the data extraction, the two investigators
exchanged their forms, and discrepancies were resolved by
discussion.
The Newcastle-Ottawa Scale (NOS)18 was used to assess the
quality of the included studies. The total score of the NOS scale was
9. Studies that scored  7 were considered as high quality, 4e6 as
fair quality, and  3 as low quality.
2.4. Statistical analysis
RRs and 95% CIs were used to evaluate the association between
OSA and cardiovascular events or mortality risk. Heterogeneity was
assessed using the Cochran Q test and I2 statistic19. A p value < 0.05
or I2 > 50% was considered as the presence of signiﬁcant hetero-
geneity, and then a random effects model was used to pool the
estimates, otherwise, the ﬁxed effect model was used. Subgroup
analyses stratiﬁed by diagnostic methods, gender, design of cohort,
duration of follow-up, etc., were conducted to explore the source of
heterogeneity and the inﬂuence of these items. To evaluate the
stability of our results, sensitivity analysis was performed by
omitting each study according to different criteria. In addition,
Egger's test was used to assess the publication bias. All of the sta-
tistical analyses were performed using Stata 11.0 (Stata Corp,
College Station, TX, USA).3. Results
3.1. Study selection
As shown in Figure 1, a total of 2558 articles were identiﬁed by
the initial search. Firstly, 423 duplicates were removed. Then, 2114
articles (2057 obviously irrelevant studies, 40 reviews and 17 cross-
sectional studies) were excluded after reviewing titles and ab-
stracts. Moreover, 10 of the remaining studies (8 without elderly
participants and 2 retrospective cohort studies) were excluded af-
ter reading the full text. Finally, a total of 11 studies were included
in this meta-analysis3,7,20e28.
3.2. Characteristics of the included studies
As shown in Table 1, a total of 11 studies with 22,046 partici-
pants were included in this meta-analysis. Of these, ﬁve studies
were distributed in Europe, three in the USA, and two in China. The
11 eligible studies included 14 cohorts, which reported the asso-
ciations between OSA and CVD (4 cohorts), CHD (6 cohorts), stroke
risk (7 cohorts), and all-cause mortality (4 cohorts), respectively.
The mean ages of participants enrolled in each of the eligible
studies, or the age range if the mean was not available, are listed in
Table 1.
Quality assessment (Table 2) showed that all of the studies
scored  7 points on the NOS scale, except for one study which
scored 6 points and two studies which scored 5 points22,27,28, which
indicated that this set of eligible studies had relatively high
qualities.
3.3. Pooled analysis
The forest plots of the meta-analysis are shown in Figure 2.
3.3.1. CVD
Signiﬁcant heterogeneity was observed among studies which
included the relationship between OSA and CVD (I2 ¼ 76.7%,
p ¼ 0.005, Figure 2A). The estimated RR and 95% CI were pooled
using a random effects model, and the result showed that OSA
could signiﬁcantly increase CVD risk in the elderly (RR ¼ 2.04, 95%
CI ¼ 1.28e3.23). Sensitivity analysis showed that the result was
reversed after removing studies which didn't use a community- or
Table 1
Characteristics of included studies in this meta-analysis.
Study Area Design of
cohort
Follow-up
(y)
Gender n (M/F) Age (y) Exposure
comparison
Study outcome
(incident cases)
RR (95% CI)
Gottlieb et al,7 2010 USA Community-
based
Median 8.7 (7.7e9.3) M 1927 64.4 AHI 30 vs. < 5 CHD 1.33 (0.91, 1.95)
F 2495 62.1 0.40 (0.12, 1.27)
Martinez-Garcia et al,20 2012 Spain Clinic-based Median 5.7 M & F 436 (288/148)  65 AHI 30 vs. < 15 CVD 2.53 (1.28, 4.99)
MI (CHD) 1.09 (0.37, 3.36)
Stroke 4.63 (1.03, 20.8)
Johansson et al,3
2012
Sweden Community-
based
 7 M & F 271 (121/150) 65e82 AHI 5 vs. < 5 CVD death 0.86 (0.40, 1.87)
Redline et al,23 2010 USA Community-
based
Median 8.7 M 2462 63.6 AHI  19.1 vs. < 4 Stroke 2.86 (1.10, 7.39)
F 2960 62.5 1.21 (0.65, 2.24)
Munoz et al,25 2006 Spain Population-based Mean 4.5 M & F 394 (225/169) 70
e100
AHI  30 vs. < 30 Stroke 2.52 (1.04, 6.10)
Johansson et al,21 2011 Sweden Community-
based
 6 M & F 331 (164/167) 65e82 AHI 30 vs. < 5 all-cause death 1.4 (0.4, 4.4)
Punjabi et al,24 2009 USA Community-
based
Mean 8.2 M 773 > 70 AHI 30 vs. < 5 all-cause death 1.27 (0.86, 1.86)
F 2392 > 70 1.14 (0.65, 2.01)
Cao et al,27,a
2014
China Clinic-based 20 M & F 1868 (956/912) 63 AHI > 5 vs.  5 CHD 2.27 (2.02, 2.56)
Stroke 3.73 (2.96, 4.71)
Ci et al,28,a
2012
China Clinic-based 20 M & F 1868 (956/912) 63 AHI > 5 vs.  5 CVD 2.94 (2.67, 3.23)
Yeboah et al,22
2011
USA Community-
based
Mean 7.5 M & F 3886 (1801/2085) 63.6 Yes vs. No b CVD 1.90 (1.21, 2.98)
CHD 2.06 (1.20, 4.16)
Stroke 1.15 (0.36, 3.74)
all-cause death 2.62 (1.51, 4.55)
Elwood et al,26
2006
UK Population-based  5 M 1851 61.8 Yes vs. No b IHD (CHD) 1.21 (0.84, 1.74)
Stroke 1.97 (1.26, 3.09)
AHI ¼ apnea hypopnea index; CHD ¼ coronary heart disease; CVD ¼ cardiovascular disease; F ¼ female; IHD ¼ ischemic heart disease; M ¼male; MI ¼myocardial infarction.
a Different kinds of outcomes with the same cohort.
b Self-administered sleep history questionnaire.
Table 2
Methodological quality of included studies in this meta-analysis.a
Study Representativeness
of the exposed
cohort
Selection of
the unexposed
cohort
Ascertainment
of exposure
Outcome of interest
not present at start of
study
Control for important
factor or additional
factor b
Outcome
assessment
Follow-up long
enough for
outcomes to occur
Adequacy of
follow-up of
cohorts
Total
quality
scores
Gottlieb
et al,7
2010
* * * * ** * * * 9
Martinez-
Garcia
et al,20
2012
d d * * ** * * * 7
Johansson
et al,3
2012
* * * * d * * * 7
Redline
et al,23
2010
* * * * ** * * * 9
Munoz
et al,25
2006
* * * * * * d * 7
Johansson
et al,21
2011
* * * * d * * * 7
Punjabi
et al,24
2009
* * * * ** * * * 9
Cao et al,27
2014
d d * * d * * * 5
Ci et al,28
2012
d d * * d * * * 5
Yeboah
et al,22
2011
d d * * ** d * * 6
Elwood
et al,26
2006
* * * * ** d d * 7
a A study could be awarded a maximum of one star for each item except for the item Control for important factor or additional factor.
b A maximum of two stars could be awarded for this item.
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Figure 2. The pooled analyses for association between OSA and (A) CVD; (B) CHD; (C) stroke; and (D) all-cause mortality. CHD ¼ coronary heart disease; CI ¼ conﬁdence interval;
CVD ¼ cardiovascular disease; F ¼ female; M ¼ male; OSA ¼ obstructive sleep apnea; RR ¼ risk ratio.
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effect on the pooled result.3.3.2. CHD
Signiﬁcant heterogeneity was found among studies which
included the relationship between OSA and CHD (I2 ¼ 79.5%,
p < 0.001, Figure 2B). The pooled RRs and 95% CIs were calculated
using a random effects model, and the result showed that no sig-
niﬁcant association existed between OSA and CHD risk in the
elderly (RR¼ 1.43, 95% CI¼ 0.96e2.23). Sensitivity analysis showed
that the result was stable (Table 3).3.3.3. Stroke
Signiﬁcant heterogeneity was observed among studies which
included the relationship between OSA and stroke (I2 ¼ 66.5%,
p ¼ 0.006, Figure 2C). The pooled RR and 95% CI were calculated
using a random effects model, and the result showed that OSA
could signiﬁcantly increase incidence of stroke in the elderlyTable 3
Results of sensitivity analyses.
Inclusion criterion CVD
n RR (95% CI) n
Total 4 2.04 (1.28, 3.23) 6
Using AHI for OSA diagnosis 3 2.01 (1.03, 3.92) 4
Adjusting for important confounders 2 2.07 (1.42, 3.02) 5
Community- or population- based design 2 1.36 (0.63, 2.93) 4
Follow-up > 5 y 4 2.04 (1.28, 3.23) 5
AHI ¼ apnea hypopnea index; CHD ¼ coronary heart disease; CI ¼ conﬁdence interval;(RR¼ 2.29, 95% CI¼ 1.49e3.51). This result was stable in sensitivity
analysis (Table 3).
3.3.4. All-cause mortality
No signiﬁcant heterogeneity was observed among studies which
included the relationship between OSA and all-cause mortality
(I2 ¼ 46.0%, p ¼ 0.135, Figure 2D). Thus, a ﬁxed effect model was
used to pool estimates. The result indicated that OSA could signif-
icantly increase mortality in the elderly (RR ¼ 1.48, 95%
CI ¼ 1.13e1.94). Sensitivity analysis showed that the result was
reversed after omitting the study of Yeboah et al22, which did not
use the apnea hypopnea index for OSA diagnosis (Table 3).
3.4. Subgroup analyses
Subgroup analyses showed obviously reduced heterogeneity
when stratiﬁed by gender, adjusting and type of design. Diagnosis
methods or duration of follow-up showed no signiﬁcant effect on
the heterogeneity (Table 4).CHD Stroke All-cause mortality
RR (95% CI) n RR (95% CI) n RR (95% CI)
1.43 (0.96, 2.13) 7 2.29 (1.49, 3.51) 4 1.48 (1.13, 1.94)
1.32 (0.75, 2.34) 5 2.60 (1.52, 4.45) 3 1.24 (0.91, 1.68)
1.27 (0.92, 1.76) 5 1.81 (1.25, 2.62) 3 1.48 (1.13, 1.95)
1.28 (0.87, 1.86) 5 1.80 (1.33, 2.45) 4 1.48 (1.13, 1.94)
1.50 (0.96, 2.34) 5 2.31 (1.23, 4.34) 4 1.48 (1.13, 1.94)
CVD ¼ cardiovascular disease; OSA ¼ obstructive sleep apnea; RR ¼ risk ratio.
Table 4
Results of subgroup analyses.
Subgroup CVD CHD Stroke All-cause mortality
n RR (95% CI) I2 (%), p n RR (95% CI) I2 (%), p n RR (95% CI) I2 (%), p n RR (95% CI) I2 (%), p
OSA diagnosis
e
Polysomnography
3 2.01 (1.03, 3.92) 79.5, 0.008 4 1.32 (0.75, 2.34) 81.4, 0.001 5 2.60 (1.52, 4.45) 65.9, 0.019 3 1.24 (0.91, 1.68) < 0.001, 0.933 a
Physician diagnosed 1 1.90 (1.21, 2.98) d 2 1.48 (0.89, 2.46) 52.3, 0.148 2 1.84 (1.21, 2.80) < 0.001, 0.400 a 1 2.62 (1.51, 4.55) d
Gender
Male d d d 2 1.27 (0.97, 1.65) < 0.001, 0.725 a 2 2.11 (1.40, 3.16) < 0.001, 0.488 a 1 1.27 (0.86, 1.86) d
Female d d d 1 0.40 (0.12, 1.30) d 1 1.21 (0.65, 2.25) d 1 1.14 (0.65, 2.00) d
Male & Female 4 2.04 (1.28, 3.23) 76.7, 0.005 3 2.24 (2.00, 2.52) < 0.001, 0.416 a 4 3.02 (1.89, 4.81) 32.2, 0.219 a 2 2.35 (1.42, 3.88) < 0.001, 0.352 a
Adjusting
Yes 2 2.07 (1.42, 3.02) < 0.001, 0.492 a 5 1.27 (0.92, 1.76) 35.4, 0.185 a 5 1.81 (1.25, 2.62) 15.4, 0.316 a 3 1.52 (0.95, 2.48) 63.9, 0.062
No 2 1.69 (0.51, 5.61) 89.6, 0.002 1 2.27 (2.02, 2.56) 2 3.64 (2.91, 4.55) < 0.001, 0.401 a 1 1.40 (0.40, 4.40) d
Type of design
Population- based 2 1.36 (0.63, 2.93) 67.0, 0.082 4 1.28 (0.87, 1.86) 50.9, 0.107 5 1.80 (1.33, 2.45) < 0.001, 0.439 a 4 1.48 (1.13, 1.94) 46, 0.135 a
Clinic-based 2 2.93 (2.67, 3.22) < 0.001, 0.668 a 2 1.95 (1.09, 3.49) 40.5, 0.195 a 2 3.75 (2.98, 4.72) < 0.001, 0.781 a d d d
Duration of follow-up
> 5 years 4 2.04 (1.28, 3.23) 76.7, 0.005 5 1.50 (0.96, 2.34) 75.2, 0.003 5 2.31 (1.23, 4.34) 72.1, 0.006 4 1.48 (1.13, 1.94) 46, 0.135 a
 5 years d d d 1 1.21 (0.84, 1.74) d 2 2.07 (1.39, 3.09) < 0.001, 0.627 a d d d
CHD ¼ coronary heart disease; CI ¼ conﬁdence interval; CVD ¼ cardiovascular disease; OSA ¼ obstructive sleep apnea; RR ¼ risk ratio.
a Without signiﬁcant heterogeneity.
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Result of Egger's test showed no potentially signiﬁcant publi-
cation bias (p ¼ 0.208).4. Discussion
In this study, we systematically reviewed and meta-analyzed
studies concerning the association between OSA and risks of
some cardiovascular events (CVD, CHD, and stroke) and all-cause
mortality in the elderly. We identiﬁed 11 eligible studies
including 22,046 participants. Our results showed that OSA could
signiﬁcantly increase the risks of CVD, stroke, and all-cause mor-
tality in the elderly, but no signiﬁcant association between OSA and
CHD incidence was found.
A few meta-analyses have been previously published on the
associations of OSA with risks of cardiovascular events and all-
cause mortality11e14. These studies, however, have not focused on
the elderly or Chinese population, and new evidence should be
considered to include in the analysis. In this current study, 11
studies were included into the meta-analysis with the restriction of
participants' average age > 60 years. The results showed that OSA
could signiﬁcantly increase the risks of CVD, stroke and all-cause
mortality in the elderly. In addition, OSA has a potential trend to
adversely affect the outcomes of CHD, though no signiﬁcant asso-
ciation was observed between OSA and CHD incidence. The rela-
tionship between OSA and cardiovascular events might be
explained by some of the prognostic factors associated with OSA. In
CHD patients, the acute nocturnal pathophysiological responses to
OSA may lead to coronary thrombosis, plaque rupture, and acute
coronary syndromes29. OSA also appears to be associated with
nocturnal ST-segment depression, which may adversely affect the
outcome of CHD patients30. Although no signiﬁcant associationwas
found between OSA and CHD in elderly people, OSA has a potential
trend to adversely affect the outcomes of CHD. Several reasons
explain the association between OSA and stroke, including
abnormal cerebral hemodynamics associatedwith OSA. Endothelial
dysfunction pathways, including intrathoracic pressure swings,
intermittent hypoxia, and recurrent arousals, may also link the
development of atherosclerosis with the pathogenesis of stroke31.
On the basis of the evidence, it appears that OSA is a risk factor
for the development of cardiovascular events. However, whetherOSA is independently related to cardiovascular events remains
controversial. In this study, the association between OSA and CVD
was no longer signiﬁcant when the clinic-based studies were
omitted, and the association between OSA and mortality was also
reversed after removing the study of Yeboah et al22 which did not
use the apnea hypopnea index for OSA diagnosis. Thus, we suggest
that clinic-based studies may be affected by a referral bias, causing
a misleading association of OSA with CVD or mortality.
This meta-analysis has some advantages. Firstly, all of the
included studies were prospective cohort studies which were more
credible. Secondly, this study targeted the association between OSA
and the risk of cardiovascular events and all-cause mortality in the
elderly. Thirdly, no publication bias was observed, indicating the
results were relatively stable. However, several limitations should
also be acknowledged. Firstly, selection bias may exist in studies
with a clinic-based design. Secondly, we included studies recruiting
participants with a mean age  60 years, but some middle-aged or
younger patients were included improperly and might affect our
results. Thirdly, although some confound factors have been
adjusted, other unavoidable confounders in observational studies
may affect our result. Finally, the duration of follow-up among the
included studies ranged from< 5 years to 20 years, whichmay have
inﬂuenced the results to some extent.
In conclusion, OSA can signiﬁcantly increase the risk of CVD,
stroke, and all-cause mortality in the elderly. However, no signiﬁ-
cant associationwas observed between OSA and CHD in the elderly.
Further clinical studies with high-quality and large samples are
needed to explore these associations and corresponding explana-
tions. Clinicians should be aware of these associations when they
care for patients with CVD or OSA.Acknowledgments
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